Laing Pharma
  • Home
  • What we do
    • GDP and QMS Consultancy
    • GDP & Quality Audits
    • QMS Remediation Projects
    • Inspection Preparation
    • SOP Services
    • Contract RP's
  • Contact Us
Laing Pharma
  • Home
  • What we do
    • GDP and QMS Consultancy
    • GDP & Quality Audits
    • QMS Remediation Projects
    • Inspection Preparation
    • SOP Services
    • Contract RP's
  • Contact Us

GDP & Quality System Audits

 The MHRA are reporting an increasing number of deficiencies found during GDP inspections, particularly those at major and critical levels, with most relating to the quality system. The purpose of our audits are to highlight gaps in your quality system that in an inspection would likely result in a deficiency. We offer a full report of our findings, as well as remediation plans to get you back on track to compliance.
Our GDP and quality system audits are performed with you for one day, and a gap analysis report will be sent to you within one working day. We have taken several steps to make things easier during the changing landscape of Covid-19, so we are able to offer our audits remotely using Microsoft Teams or Zoom, and where files are viewed using a cloud sharing service. For those who prefer the audits to take place in person, we are happy to offer a Covid-19 friendly service nationwide.  


Contact us to discuss your requirements and to see which is the right service for you.  

Copyright © 2023 MILVUS CONSULTING LTD T/A Laing Pharma - All Rights Reserved.

  • Home
  • Privacy Policy

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept